Investor Presentaiton slide image

Investor Presentaiton

Department of Health Notes to the financial statements For the year ended on 30 June 2023 6 Other assets and liabilities This section sets out those assets and liabilities that arose from the department's controlled operations and includes other assets utilised for economic benefits and liabilities incurred during normal operations: Inventories Receivables Amounts receivable for services (Holding Account) Other assets Payables Contract liabilities 6.1 Inventories Contents Current Drug supplies (at cost) Medical equipment (at cost) (a) Total inventories Notes 6.1 6.2 6.3 6.4 6.5 6.6 2023 2022 $'000 $'000 15,299 10,968 21,976 34,054 37,275 45,022 a) Includes medical equipment purchased as part of the COVID-19 Response, to be distributed to statutory authorities within the WA health system when required. At the reporting date, write-downs totalling $5.3 million have been made comprising: drug supplies which were adjusted to reflect expired stock of $4.6 million medical equipment which was adjusted to the lower of cost and net realisable value and resulted in a write-down of $0.7 million ($0.4 million in 2021-22) Please refer to note 3.5 'Other expenses'. Inventories are measured at the lower of cost and net realisable value. Costs are assigned by the method most appropriate for each class of inventory, with the majority being measured on a first in first out basis. < 169 About us Significant issues Report on operations Agency performance Operational disclosures Key performance indicators Financial disclosures and compliance • Appendix
View entire presentation